UPDATE -- Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024

Rhea-AI Summary

Amicus Therapeutics (Nasdaq: FOLD), a global biotechnology company focused on rare diseases, has announced its participation in several investor conferences in September 2024. The company will present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5 and the Cantor Global Healthcare Conference 2024 on September 17, both in New York. Additionally, management will attend the 2024 Wells Fargo Healthcare Conference on September 6.

Live audio webcasts of the presentations will be available through the investors section of the Amicus Therapeutics website. This series of conference appearances underscores the company's commitment to engaging with investors and showcasing its progress in developing treatments for rare diseases.

News Market Reaction

+0.17%

1 alert

+0.17% News Effect

On the day this news was published, FOLD gained 0.17%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

PRINCETON, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in September.

• Morgan Stanley 22^nd Annual Global Healthcare Conference in New York, NY, on Thursday, September 5, 2024, at 10:00 a.m. ET
• Cantor Global Healthcare Conference 2024 in New York, NY on Tuesday, September 17, 2024, at 1:55 p.m. ET

A live audio webcast of each presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.

Additionally, management will attend the 2024 Wells Fargo Healthcare Conference on Friday, September 6, 2024.

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on X and LinkedIn.

CONTACT:

Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809

Media:
Amicus Therapeutics
Diana Moore
Head of Global Corporate Affairs and Communications
dmoore@amicusrx.com
(609) 662-5079

FOLD–G

FAQ

When is Amicus Therapeutics (FOLD) presenting at the Morgan Stanley Global Healthcare Conference in 2024?

Amicus Therapeutics (FOLD) is presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, 2024, at 10:00 a.m. ET in New York, NY.

What investor conferences is Amicus Therapeutics (FOLD) attending in September 2024?

Amicus Therapeutics (FOLD) is attending three investor conferences in September 2024: the Morgan Stanley 22nd Annual Global Healthcare Conference, the Cantor Global Healthcare Conference 2024, and the 2024 Wells Fargo Healthcare Conference.

How can investors access the live audio webcasts of Amicus Therapeutics (FOLD) presentations?

Investors can access the live audio webcasts of Amicus Therapeutics (FOLD) presentations through the investors section of the company's corporate website at https://ir.amicusrx.com/events-and-presentations.

What is the focus of Amicus Therapeutics (FOLD) as a biotechnology company?

Amicus Therapeutics (FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering novel high-quality medicines for people living with rare diseases.